Review of Cardiovascular Disease Programs

3. Executive Summary

Executive Summary - Review of Cardiovascular Disease Programs

Page last updated: 03 May 2012

Cardiovascular disease (CVD) is the term given to a group of diseases of the heart and blood vessels. CVD includes coronary heart disease, stroke, heart failure, rheumatic fever and rheumatic heart disease, peripheral vascular disease, hypertension and hypertensive heart disease, renovascular and chronic kidney disease.

Ernst & Young has undertaken a Review of Cardiovascular Disease Programs for the Department of Health and Ageing (DoHA). The review was undertaken in the context of the National Service Improvement Framework for Heart, Stroke and Vascular Disease (NSIF), with particular attention to the identified Critical Intervention Points (CIP’s) agreed by Health Ministers in 2005. Consultation was held with jurisdictions, peak bodies and other key stakeholders. This report analyses the current state of programs for CVD management in Australia, discusses key themes emerging from research, literature review and stakeholder consultation, and recommends future options for consideration.

In this review Ernst & Young has sought to balance strategies that improve outcomes across the broad range of CVD with disease specific strategies that will significantly decrease morbidity and/or mortality from a particular disease.

In undertaking this consultancy Ernst & Young has been mindful of the significant fiscal constraints which exist and to this end acknowledge that any potential enhancement in CVD programs and services in Australia will need to occur over a number of years and be based on a logical and evidence based rollout.

Ernst & Young would like to thank the Department of Health and Ageing, the States and Territories, peak bodies, non-government organisations and individuals who took the time to speak with us and to respond to our requests for information. The information received has deepened and enriched the final report.